Related references
Note: Only part of the references are listed.Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells
Keita Nakane et al.
INTERNATIONAL JOURNAL OF UROLOGY (2012)
Sirtuins mediate mammalian metabolic responses to nutrient availability
Angeliki Chalkiadaki et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Nondegradative Ubiquitination of Apoptosis Inducing Factor (AIF) by X-Linked Inhibitor of Apoptosis at a Residue Critical for AIF-Mediated Chromatin Degradation
Eric M. Lewis et al.
BIOCHEMISTRY (2011)
Sirtuins: Molecular Traffic Lights in the Crossroad of Oxidative Stress, Chromatin Remodeling, and Transcription
Ramkumar Rajendran et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
The cAMP/PKA Pathway Rapidly Activates SIRT1 to Promote Fatty Acid Oxidation Independently of Changes in NAD+
Zachary Gerhart-Hines et al.
MOLECULAR CELL (2011)
Sirt3 Promotes the Urea Cycle and Fatty Acid Oxidation during Dietary Restriction
William C. Hallows et al.
MOLECULAR CELL (2011)
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
B. Wang et al.
ONCOGENE (2011)
Comprehensive lysine acetylomes emerging from bacteria to humans
Go-Woon Kim et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation
Evelien Rysman et al.
CANCER RESEARCH (2010)
Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressors
Jianjun Bao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Chemical Proteomics Identifies Nampt as the Target of CB30865, An Orphan Cytotoxic Compound
Tracey C. Fleischer et al.
CHEMISTRY & BIOLOGY (2010)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Regulation of Cellular Metabolism by Protein Lysine Acetylation
Shimin Zhao et al.
SCIENCE (2010)
Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment
Nica M. Borradaile et al.
AGING CELL (2009)
SIRT1 markedly extends replicative lifespan if the NAD+ salvage pathway is enhanced
Cynthia Ho et al.
FEBS LETTERS (2009)
A phosphorylation-acetylation switch regulates STAT1 signaling
Oliver H. Kraemer et al.
GENES & DEVELOPMENT (2009)
Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION?
Brittney Jung-Hynes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Small Molecule GMX1778 Is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors
Mark Watson et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
E. Lara et al.
ONCOGENE (2009)
Nampt: linking NAD biology, metabolism and cancer
Antje Garten et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells
Keitaro Kojima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Anticancer agent CHS-828 inhibits cellular synthesis of NAD
Uffe Hogh Olesen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
PBEF1/NAmPRTase/Visfatin - A potential malignant astrocytoma/glioblastoma serum marker with prognostic value
P. Sreekanth Reddy et al.
CANCER BIOLOGY & THERAPY (2008)
Biological and Potential Therapeutic Roles of Sirtuin Deacetylases
D. M. Taylor et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity
Swami R. Narala et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Sirtuins - novel therapeutic targets to treat age-associated diseases
Siva Lavu et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
Kyle Holen et al.
INVESTIGATIONAL NEW DRUGS (2008)
Fatty acid synthase inhibitors: new directions for oncology
Steven J. Kridel et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival
Hongying Yang et al.
CELL (2007)
Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 Adipocytes - A role for oxidant stress (Publication with Expression of Concern. See vol. 294, pg. 10025, 2019) (Withdrawn Publication. See vol. 295, pg. 667, 2020)
Zhibo An et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Extension of human cell lifespan by nicotinamide phosphoribosyltransferase
Eric van der Veer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells
Joy L. Little et al.
CANCER RESEARCH (2007)
Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1
Soo-Kyung Bae et al.
FEBS LETTERS (2006)
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
William C. Hallows et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2
Bjoern Schwer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
US Shah et al.
HUMAN PATHOLOGY (2006)
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy
M Muruganandham et al.
CLINICAL CANCER RESEARCH (2005)
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study
A Ravaud et al.
EUROPEAN JOURNAL OF CANCER (2005)
The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells
DF Seals et al.
CANCER CELL (2005)
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
SJ Kridel et al.
CANCER RESEARCH (2004)
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells
JR Revollo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1
KJ Bitterman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
